Lee Equity Partners

Lee Equity Partners is a New York middle-market private equity firm investing across healthcare services and financial services. The firm is oriented toward long-hold capital appreciation rather than short-cycle flipping, and within healthcare it concentrates on Care Delivery and Tech-Enabled Services platforms. There is no stated AI focus, and the strategy is firmly buyout and growth equity rather than venture.

Check sizes start at $25M and go up, signaling that Lee Equity is targeting companies that already have meaningful EBITDA and a track record. The firm operates from New York and invests primarily in the US market. Specific portfolio companies and named team members are not provided in the record available here, so founders should consult the firm’s website and recent press for an accurate picture of current holdings and partner coverage.

For early-stage AI founders in healthcare, Lee Equity is almost certainly the wrong stage of capital. The fit is for operators of profitable services businesses considering a recapitalization, founder liquidity event, or growth investment to fund expansion. If you are pre-product or pre-revenue, do not pitch them. If you run a clinical services platform doing $20M-plus in EBITDA and want a partner with healthcare and financial services pattern recognition, this is a more reasonable conversation.